Kodiak大涨75%：VEGF抗体聚合物验证性三期临床成功

2026年3月26日，Kodiak Sciences宣布VEGF抗体聚合物Zenkuda治疗糖尿病性视网膜病变（DR）的三期临床GLOW2获得硬性结果。 受此消息影响，Kodiak Sciences当天股价大涨75%，市值达到24.6亿美元。 患者基线数据如下。 此前GLOW1三期临床已经获得成功，GLOW2为GLOW1的验证性三期临床。GLOW1三期临床中，主要终点DRSS评分改善超过2-ste ...

Kodiak Sciences股价因试验结果积极而飙升

Investing.com -- Kodiak Sciences Inc. (NASDAQ:KOD)股价周四上涨26%,此前该公司公布了GLOW2的积极顶线结果,这是其针对糖尿病视网膜病变治疗药物Zenkuda(tarcocimab tedromer)的第二项3期研究。 在该研究中,62.5%接受Zenkuda治疗的患者在糖尿病视网膜病变严重程度评分上实现了≥2级改善,而假治疗患者仅为3.3%,达 ...

Wave life sciences股价腰斩：INHBE siRNA疗效不及预期

WVE-007的安全性优势尤为明显，去年12月披露的数据也显示出一定的疗效潜力，但此次更新数据没有看到明确的量效关系，让资本市场对于INHBE siRNA的想象空间和热情有所下降。目前Arrowhead和Wave Life ...
Forbes

2025 Nobel Prize In Economic Sciences Awarded To Three Scholars Studying Innovation

Joel Mokyr, Philippe Aghion and Peter Howitt have been awarded the 2025 Nobel Prize in Economics. (Photo by Jonathan Nackstrand / AFP) / ALTERNATIVE CROP (Photo by JONATHAN NACKSTRAND/AFP via Getty ...

Caris Life Sciences Inc的资讯和分析评论

2025年第四季度营收同比大幅增长125%，达到2.93亿美元；每股收益为0.28美元，超出预期；毛利率从2024年第四季度的54%提高到75%。 分子分析服务营收同比增长199%，推动了强劲的业绩表现；调整后的EBITDA达到1.06亿美元，自由现金流为3970万美元。 盘后交易中，股价上涨0.87%至18.47美元，但较六个月前仍下跌50%，较52周高点42.50美元下跌55%。 分析师维持强 ...

Setting the Stage for AI: Outcome-Driven Managed Services in Life Sciences

Life sciences organizations should modernize managed services now, focusing on operational readiness, outcome-based models, ...
Tech.co

Anthropic Targets Life Sciences Sector with New Claude Tool

Anthropic is launching Claude for Life Sciences, a new model aimed at aiding scientific research. Through integrations with leading life sciences players, the platform will help researchers at every ...
Nature

Nature Index is expanding to the applied sciences

The subject area represents the next stage of the database’s evolution, and heralds other proposed changes to journal selection and article categorization. The first Nature Index tables in the applied ...
Nature

China accounts for more than half of leading output in the applied sciences

The clear divergence in approaches to public research funding in the East and West is laid bare in the first Nature Index ranking for applied sciences. China dominates the ranking and other Asian ...